|02:00 PM - 03:00 PM GMT|
|09:00 AM - 10:00 AM ET|
|06:00 AM - 07:00 AM PT|
No one knows at the moment what the relationship will be between the United Kingdom and the European Union the day after Brexit on 31 October.
The life sciences sector is arguably the most closely harmonised within the European Union. Both medicinal products and medical devices are very much subject to Brussels-driven legislation. In addition to the regulatory issues that would result from Brexit, there could be substantial supply chain interference.
In this webinar, London life sciences lawyers will explain the possible consequences of Brexit – with either a deal, no-deal, or other potential scenarios.